Effect of L-carnitine on oxidative stress in chronic hemodialysis patients
Phase 3
- Conditions
- Metabolic disorders.Metabolic disorder, unspecified
- Registration Number
- IRCT2015112224645N2
- Lead Sponsor
- Research Vice Chancellar of Ahwaz University of Medical Sciense
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
exclusion criteria: any acute illness of up to one month prior to the study or during the study, is leading to hospitalization?2 patients who have known allergies to L-carnitine? cirrhosis of the liver or AST, LT> 45? Patients who are taking vitamin E or C during the study or any known antioxidant. (From 2 weeks before and 2 weeks after starting the drug L-carnitine)? previous failure EF <35%.
all over 18 years and were undergoing hemodialysis three times a week for at least three months past the initiation of dialysis .
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oxidized LDL. Timepoint: Before the start of the study and 12 weeks later we measured serum levels of LDL. Method of measurement: Instrumental method based on mg / dl.
- Secondary Outcome Measures
Name Time Method MDA. Timepoint: Before the start of the study and 12 weeks later we measured serum levels of MDA. Method of measurement: Instrumental method based on mg /dl.